Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

News · February 23, 2022

ASCO GU 2022: TROPHY-U-01 Suggests Promise for Second-Line Sacituzumab Govitecan Plus Pembrolizumab in Metastatic Urothelial Carcinoma

The combination of antibody-drug conjugates and immune checkpoint inhibitors should be studied further

PracticeUpdate Editorial Team


Further Reading